ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 36 filers reported holding ESSA PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148 | – | 48 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 48 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 48 | +71.4% | 0.00% | – |
| Q3 2020 | $0 | – | 28 | -9.7% | 0.00% | – |
| Q1 2020 | $0 | – | 31 | -53.7% | 0.00% | – |
| Q3 2019 | $0 | – | 67 | -18.3% | 0.00% | – |
| Q2 2019 | $0 | – | 82 | +115.8% | 0.00% | – |
| Q1 2019 | $0 | – | 38 | -56.8% | 0.00% | – |
| Q4 2018 | $0 | – | 88 | +6.0% | 0.00% | – |
| Q3 2018 | $0 | – | 83 | +112.8% | 0.00% | – |
| Q2 2018 | $0 | – | 39 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |